Drugs / Infusion of concomitant Donor Derived Vertebral Bone Marrow
Infusion of concomitant Donor Derived Vertebral Bone Marrow
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05973734 | Apr 2024 → Dec 2030 expected | — | Stanford University | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infusion of concomitant Donor Derived Vertebral Bone Marrow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05973734 ↗ |
| Modality | Cell therapy | “immune cells from the bone marrow of the islet donor” NCT05973734 ↗ |
| Route | Other | “the VBM cells will be infused in one time window: on day 0-1” NCT05973734 ↗ |